Ir.amicusrx.com

Amicus Therapeutics to Present at the Bank of America 2024 …

WEBPRINCETON, N.J., May 08, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in a fireside chat at the Bank …

Actived: 6 days ago

URL: https://ir.amicusrx.com/news-releases/news-release-details/amicus-therapeutics-present-bank-america-2024-health-care

Amicus Therapeutics and the University of Pennsylvania Announce …

WEBExclusive Disease-Specific Worldwide Rights to Penn’s Next Generation Gene Therapy Technologies from the Wilson Lab for the Majority of Lysosomal …

Category:  Health Go Health

Amicus Therapeutics Announces Presentations and Posters at the …

WEBPHILADELPHIA, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and …

Category:  Health Go Health

Amicus Therapeutics Announces Presentations and Posters at the …

WEBCRANBURY, N.J., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on discovering, …

Category:  Health Go Health

Amicus Therapeutics to Present at the Bank of America 2023 …

WEBPHILADELPHIA, May 02, 2023 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in a fireside chat at the Bank …

Category:  Health Go Health

U.S. FDA Defers Action on Filing for AT-GAA in Late-onset Pompe …

WEBFDA Issues Deferred Action Letter on AT-GAA Regulatory Filing Due to the Inability to Conduct Required Manufacturing Site Inspection Prior to the PDUFA Action …

Category:  Health Go Health

Amicus Therapeutics Announces FDA Approval and Launch of …

WEBThe site you are about to enter is intended for US healthcare professionals. Please confirm you are a US healthcare professional.

Category:  Health Go Health

Amicus Therapeutics Announces Presentations and Posters at the …

WEBPHILADELPHIA, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), today announced that two oral presentations and 11 posters across its …

Category:  Health Go Health

Amicus Therapeutics Announces Approval and Launch of New …

WEBPombiliti ® (cipaglucosidase alfa) + Opfolda ® (miglustat) Approved for Adults Living with Late-Onset Pompe Disease in Great Britain. National Institute for …

Category:  Health Go Health

Amicus Therapeutics Launches Galafold™ (Migalastat) for …

WEBNational Institute for Health and Care Excellence (NICE) Publishes Final Guidance Covering Reimbursement of Galafold for Fabry Disease . CRANBURY, N.J., Feb. 27, …

Category:  Health Go Health

Amicus Therapeutics' CEO John F. Crowley to Advocate for Rare …

WEBSpeaking at Research!America National Health Research Forum with FDA Commissioner Hamburg. Moderating Panel Discussion on Capitol Hill at Rare Disease …

Category:  Health Go Health

FDA Approves Galafold™ (migalastat) for the

WEBFirst Precision and First Oral Medicine for Fabry Disease Approved for 348 Amenable GLA Variants. Galafold is the First New Treatment Option for Fabry Disease in the U.S. in …

Category:  Medicine Go Health

Press Releases Investor Relations Amicus Therapeutics

WEBPress Releases. Year. 2024. May 9, 2024. Amicus Therapeutics Announces First Quarter 2024 Financial Results and Corporate Updates. May 8, 2024. Amicus Therapeutics to …

Category:  Health Go Health

Amicus Therapeutics Announces European Commission Approval …

WEBGalafold® is the First and Only Oral Therapy Approved in the EU for the Long-term Treatment of Adolescents with Fabry Disease Aged 12 years and older with …

Category:  Health Go Health

Amicus Therapeutics Announces Full-Year 2023 Financial Results …

WEBGalafold (migalastat) net product sales for the full-year 2023 were $387.8 million, representing a year-over-year increase of 18%, or 17% at CER.Fourth quarter …

Category:  Health Go Health

Amicus Therapeutics Announces Approval for Galafold™ …

WEBCRANBURY, N.J., Sept. 14, 2017 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD) announced that Health Canada has approved the oral precision …

Category:  Health Go Health

Amicus Therapeutics Announces Presentation and Posters at the …

WEBPHILADELPHIA, March 10, 2022 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), today announced one oral presentation and two posters highlighting its …

Category:  Health Go Health

AMICUS THERAPEUTICS EXPANDS INTELLECTUAL PROPERTY …

WEBAMICUS THERAPEUTICS EXPANDS INTELLECTUAL PROPERTY ESTATE Issuance of Fourth U.S. Patent Secures Company's Proprietary Position New Brunswick, NJ - …

Category:  Health Go Health

Cowen 44th Annual Health Care Conference Amicus Therapeutics

WEBThe site you are about to enter is intended for US healthcare professionals. Please confirm you are a US healthcare professional.

Category:  Health Go Health

AMICUS THERAPEUTICS INC SECURITIES AND EXCHANGE …

WEBus03152w1099_020420.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment …

Category:  Health Go Health

NUMB E R OF S HAR E S B E NE F IC IAL LY R E P ORT ING

WEBC U S I P N o. 03152W109 13G / A P age 3 of 7 P age s 1 NAME OF R E P ORT ING P E R S ON B e hz a d Agha z a de h 2 C HE C K T HE AP P R OP R IAT E B OX IF A ME …

Category:  Health Go Health